Oral Potentially Malignant Disorders

Cancer of the oral cavity accounts for approximately 3% of all malignancies diagnosed annually and found in 270,000 patients worldwide. During this conference, Dr. Alessandro Villa will help you identify oral malignant disorders and summarize current definitions of oral potentially malignant disorders.  

Target Audience

Primary Care Physicians, Dentists, Otolaryngologists, Gastroenterologists, Radiologists, Medical Oncologists, Oral Maxillofacial Surgeons, Surgeons, Pathologists, Hospitalists, Nurses, Nurse Practitioners and Physician Assistants. 

Learning Objectives

  • Define potentially malignant oral disorders and identify patients with these disorders.
  • Apply pathology-based treatment ladder for oral malignant disorders.
Additional information
Bibliography: 
  • Mello, F. W., Miguel, A. F. P., Dutra, K. L., Porporatti, A. L., Warnakulasuriya, S., Guerra, E. N. S., & Rivero, E. R. C. (2018). Prevalence of oral potentially malignant disorders: a systematic review and meta‐analysis. Journal of Oral Pathology & Medicine, 47(7), 633-640.
  • Villa, A., & Sonis, S. (2018). Oral leukoplakia remains a challenging condition. Oral diseases, 24(1-2), 179-183.
  • Villa, A., & Gohel, A. (2014). Oral potentially malignant disorders in a large dental population. Journal of Applied Oral Science, 22(6), 473-476
  • Villa, A., Menon, R. S., Kerr, A. R., De Abreu Alves, F., Guollo, A., Ojeda, D., & Woo, S. B. (2018). Proliferative leukoplakia: proposed new clinical diagnostic criteria. Oral diseases, 24(5), 749-760.
  • Chau, L., Jabara, J. T., Lai, W., Svider, P. F., Warner, B. M., Lin, H. S., ... & Fribley, A. M. (2017). Topical agents for oral cancer chemoprevention: A systematic review of the literature. Oral oncology, 67, 153-159.
  • Napier, S. S., & Speight, P. M. (2008). Natural history of potentially malignant oral lesions and conditions: an overview of the literature. Journal of oral pathology & medicine, 37(1), 1-10.
  • Warnakulasuriya, S. (2018). Clinical features and presentation of oral potentially malignant disorders. Oral surgery, oral medicine, oral pathology and oral radiology, 125(6), 582-590.

Available Topics

Miami Cancer Institute Online Series (Multiple Modules)
This online educational series features Miami Cancer Institute (MCI) physician experts and national subject matter experts who have presented at our recent symposiums. Topics highlight the latest advances in cancer imaging, chemotherapy, surgical interventions, radiotherapy and proton therapy. Visit us often, as this catalog will be updated frequently.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Florida Board of Dentistry
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
Course opens: 
04/01/2020
Course expires: 
03/31/2022

Alessandro Villa, DDS, Ph.D., MPH
Chief of Oral Medicine
University of San Francisco
San Francisco, California 

Alessandro Villa, DDS, Ph.D., MPH,  faculty for this educational activity, has received grant/research support from Bristol Meyers Squibb. He is also a consultant for Primary Endpoint Solution. He will include off-label or unapproved product usage in his presentation or discussion.

Guilherme Rabinowits, M.D., symposium director, is a consultant with Emd Serono, Pfizer, Regeneron, Sanofi, Castle and Merck. He is a stockholder of Regeneron and Syros Pharmaceuticals. 

All of the relevant financial relationships listed for these individuals have been mitigated.

Geoffrey Young, M.D., symposium director, has no relevant financial relationship with ineligible companies* to disclose.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*.

*Ineligible companies -- Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
              
Baptist Health South Florida designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Florida Board of Dentistry
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
Please login or register to take this course.

Required Hardware/software

PC/Mac Users
PC/Mac Users

This site is supported on the most recent stable releases of the following browsers:

Click Here to Download Google Chrome
Google Chrome		Microsoft Edge
Microsoft Edge		Safari
Safari		Moxilla Firefox
Mozilla Firefox
Internet Explorer

Attention: Internet Explorer Users
This site offers limited support for Internet Explorer 11 (IE11). When using IE11, you will be prompted to download course videos instead of viewing them in the browser. After the course video downloads, the recordings will play.

Mobile Users
Mobile Users

This site is supported on the following mobile devices:

  • Apple iOS mobile devices running iOS 10 or later
  • Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
Technical Support

If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.